Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

eribulin mesylate

(er-eh-BYOO-lin MEH-zih-layt)
A drug used to treat certain types of breast cancer and liposarcoma (a type of soft tissue sarcoma) that have already been treated with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Eribulin mesylate blocks cell growth by stopping cell division and may kill cancer cells. It is a type of antimicrotubule agent. Also called E7389 and Halaven.
More Information
Search NCI's Dictionary of Cancer Terms